Page last updated: 2024-08-26

arsenic and HPV Infection

arsenic has been researched along with HPV Infection in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's7 (77.78)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Akinjobi, Z; Jeon, S; Niemann, D; Rahman, HH1
Akhtar, A; Bell, C; Ghali, L; Wang, SX; Wen, X1
Gao, P; Wang, H; Zheng, J1
Bandi, S; Dogra, S; Gupta, S; Viswanathan, P1
Duru, N; Guo, Q; He, G; Kong, X; Li, JJ; Sui, L; Wan, B; Wang, L; Wang, Q; Wu, X; Yu, L; Zhang, P; Zhou, Y1
Ghali, L; Iles, RK; Li, D; Liu, S; Wen, X; Zhang, Y1
Hristamyan, A1
Khristamian, A1
Halder, A; Pal, P1

Other Studies

9 other study(ies) available for arsenic and HPV Infection

ArticleYear
Arsenic exposure and prevalence of human papillomavirus in the US male population.
    Environmental science and pollution research international, 2023, Volume: 30, Issue:1

    Topics: Arsenic; Arsenicals; Cacodylic Acid; Environmental Exposure; Human Papillomavirus Viruses; Humans; Male; Nutrition Surveys; Papillomavirus Infections; Prevalence; United States

2023
Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study.
    International journal of molecular sciences, 2018, Apr-04, Volume: 19, Issue:4

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Drug Compounding; Drug Delivery Systems; Female; Humans; Liposomes; Oxides; Papillomavirus Infections; Particle Size; Static Electricity; Uterine Cervical Neoplasms

2018
Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells.
    Biochemical and biophysical research communications, 2014, Sep-05, Volume: 451, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Female; HeLa Cells; Human papillomavirus 16; Humans; Oncogene Proteins, Viral; Oxides; Papillomavirus E7 Proteins; Papillomavirus Infections; Repressor Proteins; Retinoblastoma Protein; Transcription Factor AP-1; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms

2014
Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma.
    Cancer letters, 2015, Jan-28, Volume: 356, Issue:2 Pt B

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Carcinoma, Renal Cell; Cell Cycle; Cell Proliferation; Cell Transformation, Viral; Cisplatin; Comet Assay; DNA Breaks, Double-Stranded; Drug Synergism; Histones; Human papillomavirus 16; Humans; Kidney Neoplasms; Kidney Tubules; Oncogene Proteins, Viral; Oxides; Papillomavirus E7 Proteins; Papillomavirus Infections; Promoter Regions, Genetic; Repressor Proteins; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2015
YY1 is a novel potential therapeutic target for the treatment of HPV infection-induced cervical cancer by arsenic trioxide.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; DNA Primers; Female; HeLa Cells; Human papillomavirus 16; Humans; Oxides; Papillomavirus Infections; Polymerase Chain Reaction; RNA, Messenger; Uterine Cervical Neoplasms; YY1 Transcription Factor

2011
Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.
    Anti-cancer drugs, 2012, Volume: 23, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; HeLa Cells; Humans; Oncogene Proteins, Viral; Oxides; Papillomavirus Infections; Repressor Proteins; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms

2012
[Researching the effectiveness and the relevancy of combined therapy with Polygynax and Pharmatex in the cases with proved HPV infection or suspicion of such infection].
    Akusherstvo i ginekologiia, 2011, Volume: 50 Suppl 2

    Topics: Adult; Antiviral Agents; Arsenicals; Contraceptive Agents; Drug Combinations; Female; Genital Diseases, Female; Humans; Neomycin; Nystatin; Papillomaviridae; Papillomavirus Infections; Polymyxins; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Viral; Young Adult

2011
[Conservative treatment of women with genital HPV. Results of Polygynax and Pharmatex combination].
    Akusherstvo i ginekologiia, 2007, Volume: 46 Suppl 2

    Topics: Arsenicals; Contraceptive Agents, Female; Drug Combinations; Female; Genital Diseases, Female; Genitalia, Female; Humans; Neomycin; Nystatin; Papillomavirus Infections; Polymyxins

2007
Is There Any Role of Arsenic Toxicity in HPV Related Oral Squamous Cell Carcinoma?
    Biological trace element research, 2019, Volume: 188, Issue:2

    Topics: Arsenic; Arsenic Poisoning; Carcinoma, Squamous Cell; Case-Control Studies; DNA, Viral; Female; Hair; Human papillomavirus 16; Humans; India; Male; Mouth Mucosa; Mouth Neoplasms; Papillomavirus Infections; Prevalence

2019